XBiotech USA Inc., an Austin life science company, has acquired - TopicsExpress



          

XBiotech USA Inc., an Austin life science company, has acquired the patent estate from Strox Biopharmaceuticals that relate to antibody therapies for methicillin resistant staph infections, or MRSA. The financial details of the deal were not revealed but include an upfront cash payment, royalty payments and the agreement by XBiotech to assume all costs […] Related posts: Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences Mass Life Sciences Center Announces 2011 Small Biz Matching Grants AmpliPhi Signs Exclusive License With University of Leicester, UK
Posted on: Mon, 07 Apr 2014 14:45:34 +0000

Trending Topics



Recently Viewed Topics




© 2015